APA

Sternberg C. N., Saad F., Graff J. N., Peer A., Vaishampayan U. N., Leung E., Rosenbaum E., Gurney H., Epstein R. J., Davis I. D., Wu B., Trandafir L., Wagner V. J. & Hussain M. (20210106). A randomised phase II trial of three dosing regimens of radium-223 in patients with bone metastatic castration-resistant prostate cancer. : Annals of oncology : official journal of the European Society for Medical Oncology.

Chicago

Sternberg C N, Saad F, Graff J N, Peer A, Vaishampayan U N, Leung E, Rosenbaum E, Gurney H, Epstein R J, Davis I D, Wu B, Trandafir L, Wagner V J and Hussain M. 20210106. A randomised phase II trial of three dosing regimens of radium-223 in patients with bone metastatic castration-resistant prostate cancer. : Annals of oncology : official journal of the European Society for Medical Oncology.

Harvard

Sternberg C. N., Saad F., Graff J. N., Peer A., Vaishampayan U. N., Leung E., Rosenbaum E., Gurney H., Epstein R. J., Davis I. D., Wu B., Trandafir L., Wagner V. J. and Hussain M. (20210106). A randomised phase II trial of three dosing regimens of radium-223 in patients with bone metastatic castration-resistant prostate cancer. : Annals of oncology : official journal of the European Society for Medical Oncology.

MLA

Sternberg C N, Saad F, Graff J N, Peer A, Vaishampayan U N, Leung E, Rosenbaum E, Gurney H, Epstein R J, Davis I D, Wu B, Trandafir L, Wagner V J and Hussain M. A randomised phase II trial of three dosing regimens of radium-223 in patients with bone metastatic castration-resistant prostate cancer. : Annals of oncology : official journal of the European Society for Medical Oncology. 20210106.